Cargando…

Patch testing in drug cutaneous adverse reactions: value of the extemporaneous preparations

Detalles Bibliográficos
Autores principales:	Assier, Haudrey, Gener, Gwendoline, Valeyrie-Allanore, Laurence, Wolkenstein, Pierre, Chosidow, Olivier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127559/ http://dx.doi.org/10.1186/2045-7022-4-S3-P105

Ejemplares similares

Usefulness of patch tests in drug adverse reaction induced by tetrazepam and anti-inflammatory drugs
por: Assier, Haudrey, et al.
Publicado: (2014)

Mechanisms that limit proliferative potential of drug-specific LTT in drug-induced severe cutaneous adverse reaction patients
por: Valeyrie-Allanore, Laurence, et al.
Publicado: (2014)

The Extent of Extemporaneous Preparation and Regulatory Framework of Extemporaneous Compounding in Latvia
por: Kiseļova, Olga, et al.
Publicado: (2019)

Clinical characteristics predicting internal neurofibromas in 357 children with neurofibromatosis-1: results from a cross-selectional study
por: Sbidian, Emilie, et al.
Publicado: (2012)

Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966
por: Bergqvist, Christina, et al.
Publicado: (2020)

Stability of extemporaneously prepared sitagliptin phosphate solution
por: Zaid, Abdel Naser, et al.
Publicado: (2022)

Extemporaneous Vesicant
por: Darcq,
Publicado: (1844)

Chemotherapy for the treatment of malignant peripheral nerve sheath tumors in neurofibromatosis 1: a 10-year institutional review
por: Zehou, Ouidad, et al.
Publicado: (2013)

Toxic epidermal necrolysis, DRESS, AGEP: Do overlap cases exist?
por: Bouvresse, Sophie, et al.
Publicado: (2012)

Utility of 18F-FDG PET with a Semi-Quantitative Index in the Detection of Sarcomatous Transformation in Patients with Neurofibromatosis Type 1
por: Combemale, Patrick, et al.
Publicado: (2014)

Critical Aspects in the Preparation of Extemporaneous Flecainide Acetate Oral Solution for Paediatrics
por: Casiraghi, Antonella, et al.
Publicado: (2021)

Extemporaneously compounded medicines [Correction]
Publicado: (2017)

Extemporaneous Substitute for the Short Forceps in Midwifery
por: Baillie,
Publicado: (1870)

Health Tract, No. 243: Extemporaneous Surgery
Publicado: (1866)

Extemporaneously compounded liquid formulations of clofazimine
por: Taneja, R., et al.
Publicado: (2023)

At-Risk Phenotype of Neurofibromatose-1 Patients: A Multicentre Case-Control Study
por: Sbidian, Emilie, et al.
Publicado: (2011)

Metabolic Tumour Burden Measured by (18)F-FDG PET/CT Predicts Malignant Transformation in Patients with Neurofibromatosis Type-1
por: Van Der Gucht, Axel, et al.
Publicado: (2016)

Efficacy and safety of an extemporaneous preparation of 2% ganciclovir eye drops in CMV anterior uveitis
por: Keorochana, Narumon, et al.
Publicado: (2017)

Prevalence, Risk, and Challenges of Extemporaneous Preparation for Pediatric Patients in Developing Nations: A Review
por: Yuliani, Sri Hartati, et al.
Publicado: (2023)

Stability of Diazoxide in Extemporaneously Compounded Oral Suspensions
por: Friciu, Mihaela, et al.
Publicado: (2016)

Extemporaneous Remarks on Surgical Cases in the Royal Infirmary
por: Lyon, William
Publicado: (1865)

Stability of gabapentin in extemporaneously compounded oral suspensions
por: Friciu, Mihaela, et al.
Publicado: (2017)

Stability of extemporaneously compounded amiloride nasal spray
por: Yellepeddi, Venkata, et al.
Publicado: (2020)

Extemporaneous Compounding: Selective Pharmacists with Separate Skill
por: Mohiuddin, AK
Publicado: (2019)

Extemporaneous Compounding Practice for Dermatologic Preparations in Ethiopian Public Hospitals: Regulatory Requirements and Quality Concerns
por: Selam, Muluken Nigatu, et al.
Publicado: (2021)

An Atypical Cutaneous Reaction to Rivastigmine Transdermal Patch
por: Grieco, T., et al.
Publicado: (2011)

Prevalence, determinants, and characteristics of extemporaneous compounding in Jordanian pharmacies
por: AlKhatib, Hatim S., et al.
Publicado: (2019)

Extemporaneous Compounding and Physiological Modeling of Amlodipine/Valsartan Suspension
por: Aabed, Wafa' J., et al.
Publicado: (2021)

Erratum to: Extemporaneous Compounding: Selective Pharmacists with Separate Skill
por: Mohiuddin, AK
Publicado: (2020)

Analysis of Extemporaneous Prescriptions Prescribed by Dermatovenerologists in Latvia and Comparison with Standardized Compounded Preparation Monographs of Germany and USA
por: Kiseļova, Olga, et al.
Publicado: (2020)

Mortality Associated with Neurofibromatosis 1: A Cohort Study of 1895 Patients in 1980-2006 in France
por: Duong, Tu Anh, et al.
Publicado: (2011)

Kikuchi Disease-Like Inflammatory Pattern in Cutaneous Inflammatory Infiltrates Without Lymph Node Involvement: A New Clue for the Diagnosis of Lupus?
por: Thai, Lan-Huong, et al.
Publicado: (2015)

Patch testing and cross sensitivity study of adverse cutaneous drug reactions due to anticonvulsants: A preliminary report
por: Shiny, T N, et al.
Publicado: (2017)

Physicochemical and Microbiological Stability of the Extemporaneous Sildenafil Citrate Oral Suspension
por: Sae Yoon, Attawadee, et al.
Publicado: (2015)

A Systematic Review of the Stability of Extemporaneous Pediatric Oral Formulations
por: Belayneh, Anteneh, et al.
Publicado: (2021)

ADVERSE CUTANEOUS DRUG REACTION
por: Nayak, Surajit, et al.
Publicado: (2008)

Cutaneous Adverse Reactions of Amiodarone
por: Jaworski, Krzysztof, et al.
Publicado: (2014)

Adverse cutaneous drug reactions
por: Adibi, Neda
Publicado: (2014)

The comparison of extemporaneous preparations of omeprazole, pantoprazole oral suspension and intravenous pantoprazole on the gastric pH of critically ill-patients
por: Dabiri, Yasamin, et al.
Publicado: (2015)

Patient Adherence to Olmesartan/Amlodipine Combinations: Fixed Versus Extemporaneous Combinations
por: Levi, Miriam, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_v5f930k2sp5ptj8odbb5obv799